QX-1206

N/A

Report date: 2024/11/20 20:00:31
NME

Base Information

Drug NameQX-1206
Drug Alias NameQX1206QX-1206
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA > aiRNA
Mechanisms of ActionRNA interference
TargetsUpdating
Therapy Area/IndicationsDiabetes Mellitus, Type 2Metabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator Companies1globe Health Institute Llc
China Registration ClassN/A

Develop Information

Active Companies1globe Health Institute Llc
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2Metabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A